Hightower 6M Holding’s Encompass Health EHC Stock Holding History

Hightower 6M Holding’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,329	Closed	-$245K	–	342
2022 Q1	$245K	Buy	+4,329	New	+$226K	0.02%	221

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hightower 6M Holding's EHC Position: Q2 2022 in Review

Hightower 6M Holding sold out of Encompass Health (EHC) in Q2 2022, closing a stake of 4,329 shares — an estimated $245K sold.

Hightower 6M Holding first reported a position in EHC in Q1 2022 and held it in 1 quarter. The position peaked at $245K in Q1 2022. 395 funds tracked by Wall St. Rank hold EHC as of Q2 2022.

Hightower 6M Holding reported no remaining Encompass Health position as of Q2 2022 after selling out during the quarter.
Hightower 6M Holding sold 4,329 Encompass Health shares in Q2 2022, an estimated $245K.
Hightower 6M Holding first reported a position in Encompass Health in Q1 2022 and held it in 1 quarter.
Hightower 6M Holding's Encompass Health position peaked at $245K in Q1 2022.
395 funds tracked by Wall St. Rank held Encompass Health as of Q2 2022.

Based on Hightower 6M Holding's 13F filing for Q2 2022, filed 27 Jul 2022.